MedTrace Logo

Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers

NCT00767182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2016-03-23

No results posted yet for this study

Summary

Pregnancy complications called PVP are mainly responsible for perinatal mortality. In these cases, the placenta is smaller and often the centre of thrombotic lesions. The estimation of the placenta volume by 3D ultrasound coupled with growth factors and D-Dimers measures could improve the understanding of these pathologies to optimize their detection.

Conditions

  • Placenta Vascular Malformation

Interventions

OTHER

blood sample

biological markers evaluated : D-Dimer, sEPCR

Sponsors & Collaborators

  • Groupe de Recherche sur la Thrombose

    collaborator OTHER

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Céline CHAULEUR, MD · CHU de Saint-Etienne

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00767182 on ClinicalTrials.gov